Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
270.00    0.00 (0.00%)
Bid:
262.00
Ask:
271.00
Spread: 9.00 (3.435%)
Market Cap: £241.80m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Pre-Close Period Statement

14 Jul 2005 07:00

Wilmington Group Plc14 July 2005 For immediate release 14th July 2005 WILMINGTON GROUP PLC PRE-CLOSE PERIOD STATEMENT Wilmington Group plc ("Wilmington" or the "Group"), the professional informationand training group, today issues its pre-close period statement in respect ofthe year to 30 June 2005. Trading performance for the year to 30 June 2005 is anticipated to be in linewith our expectations and significantly ahead of the corresponding period ended30 June 2004. This reflects the considerable progress that has been made duringthe year towards our strategy of focusing on selected professional businessmarkets where we can develop a range of complementary information and training/event activities. We anticipate that the strongest growth in both turnover and profits will havecome from the Legal and Regulatory division where excellent progress has beenmade in many areas. The information and publishing activities have continued tobenefit from the growth in e-revenues and are expected to produce excellentlevels of profitability. We were delighted that the weekly magazine 'SolicitorsJournal' has recently been voted Legal Journal of the Year. Our trainingbusinesses are expected to have generated profits at the higher end of ourexpectations with strong performances from Scotland, Ireland and the Immigrationand Asylum accreditation programme. The major reorganisation of our Design and Construction division has beensuccessfully completed. The relocation of staff and creation of new managementteams has been effective. We are delighted that this division is expected toshow a return to profit in the year to 30 June 2005 after a loss in the yearended 30 June 2004. We anticipate further progress in the year to 30 June 2006. Elsewhere in the Group the process of investing in the launch of new productsand the ongoing development of new initiatives continues. We continue to pursueour strategy of concentrating on our core markets and developing clusters ofcomplementary activities within those markets. Outlook The Board is encouraged by the progress made in 2005 and is confident that itsstrategy of focusing on key professional business markets will result in furtherprogress this financial year. It is anticipated that Wilmington will announce its preliminary results for theyear ended 30 June 2005 in mid September 2005. For further information please contact: Wilmington Group Charles Brady (Chief Executive) 0207 422 6800Basil Brookes (Finance Director) 0207 422 6800 Weber Shandwick Square Mile Nick Oborne, Kirsty Raper or Yvonne Alexander 0207 067 0700 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20254:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:35 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSShare repurchase programme
17th Feb 20257:00 amRNSHalf-year Report
17th Jan 20259:42 amRNSNotice of Half Year Results
4th Dec 20247:00 amRNSDirector/PDMR Shareholding
28th Nov 202411:03 amRNSResult of AGM
25th Nov 20241:37 pmRNSHolding(s) in Company
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
8th Nov 20243:13 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSAcquisition of Phoenix Health & Safety
21st Oct 20241:47 pmRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSIssue of Ordinary Shares
1st Oct 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSFinancial results for the year ended 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
29th Jul 20248:59 amRNSDirector Declaration
24th Jul 20247:00 amRNSTrading Statement
10th Jul 202410:57 amRNSHolding(s) in Company
2nd Jul 20242:51 pmRNSTotal Voting Rights - Replacement
1st Jul 20247:00 amRNSTotal Voting Rights
27th Jun 20247:00 amRNSUK Healthcare Business sold for £26.3 million
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.